Your browser doesn't support javascript.
loading
BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.
Ko, Josephine Mun-Yee; Ning, Lvwen; Zhao, Xue-Ke; Chai, Annie Wai Yeeng; Lei, Lisa Chan; Choi, Sheyne Sta Ana; Tao, Lihua; Law, Simon; Kwong, Ava; Lee, Nikki Pui-Yue; Chan, Kin-Tak; Lo, Anthony; Song, Xin; Chen, Pei-Nan; Chang, Yun-Li; Wang, Li Dong; Lung, Maria Li.
Affiliation
  • Ko JM; Department of Clinical Oncology, University of Hong Kong, Hong Kong, People's Republic of China.
  • Ning L; Department of Clinical Oncology, University of Hong Kong, Hong Kong, People's Republic of China.
  • Zhao XK; Henan Key Laboratory for Esophageal Cancer Research of the First Affiliated Hospital, State Key Laboratory for Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Chai AWY; Department of Clinical Oncology, University of Hong Kong, Hong Kong, People's Republic of China.
  • Lei LC; Department of Clinical Oncology, University of Hong Kong, Hong Kong, People's Republic of China.
  • Choi SSA; Department of Clinical Oncology, University of Hong Kong, Hong Kong, People's Republic of China.
  • Tao L; Department of Clinical Oncology, University of Hong Kong, Hong Kong, People's Republic of China.
  • Law S; Department of Surgery, University of Hong Kong, Hong Kong, People's Republic of China.
  • Kwong A; Department of Surgery, University of Hong Kong, Hong Kong, People's Republic of China.
  • Lee NP; Hereditary Breast Cancer Family Registry Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, People's Republic of China.
  • Chan KT; Department of Surgery, University of Hong Kong, Hong Kong, People's Republic of China.
  • Lo A; Department of Surgery, University of Hong Kong, Hong Kong, People's Republic of China.
  • Song X; Division of Anatomical Pathology, Queen Mary Hospital, Hong Kong, People's Republic of China.
  • Chen PN; Henan Key Laboratory for Esophageal Cancer Research of the First Affiliated Hospital, State Key Laboratory for Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Chang YL; Henan Key Laboratory for Esophageal Cancer Research of the First Affiliated Hospital, State Key Laboratory for Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Wang LD; Department of Gastroenterology, Shanghai University of Medicine and Health Sciences, Affiliated Zhoupu Hospital, Shanghai, People's Republic of China.
  • Lung ML; Henan Key Laboratory for Esophageal Cancer Research of the First Affiliated Hospital, State Key Laboratory for Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
Int J Cancer ; 146(4): 1042-1051, 2020 02 15.
Article in En | MEDLINE | ID: mdl-31396961

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Germ-Line Mutation / BRCA2 Protein / Genes, BRCA2 / Esophageal Squamous Cell Carcinoma Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Cancer Year: 2020 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Germ-Line Mutation / BRCA2 Protein / Genes, BRCA2 / Esophageal Squamous Cell Carcinoma Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Cancer Year: 2020 Document type: Article Country of publication: